BC Platforms acquires Medexprim
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
BC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.
BC Platforms strengthens its global offering with the acquisition of 4Pharma, combining CRO expertise with advanced Real-World Data technology.
BC Platforms powers data analysis for the HELIOS study in Singapore, advancing the nation’s precision medicine programme and enabling insights across major chronic diseases.